These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12066229)
1. Treatment of hepatocellular carcinoma with long acting somatostatin analogues. Samonakis DN; Moschandreas J; Arnaoutis T; Skordilis P; Leontidis C; Vafiades I; Kouroumalis E Oncol Rep; 2002; 9(4):903-7. PubMed ID: 12066229 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage. Plentz RR; Tillmann HL; Kubicka S; Bleck JS; Gebel M; Manns MP; Rudolph KL J Gastroenterol Hepatol; 2005 Sep; 20(9):1422-8. PubMed ID: 16105131 [TBL] [Abstract][Full Text] [Related]
3. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Yuen MF; Poon RT; Lai CL; Fan ST; Lo CM; Wong KW; Wong WM; Wong BC Hepatology; 2002 Sep; 36(3):687-91. PubMed ID: 12198662 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide. Rabe C; Pilz T; Allgaier HP; Halm U; Strasser C; Wettstein M; Sauerbruch T; Caselmann WH Z Gastroenterol; 2002 Jun; 40(6):395-400. PubMed ID: 12055662 [TBL] [Abstract][Full Text] [Related]
5. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. Li YY; Sha WH; Zhou YJ; Nie YQ J Gastroenterol Hepatol; 2007 Dec; 22(12):2148-54. PubMed ID: 18031373 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience. Montella L; Addeo R; Caraglia M; Faiola V; Guarrasi R; Vincenzi B; Palmeri A; Capasso E; Nocera V; Tarantino L; Ariete M; Martorelli A; Del Prete S Oncol Rep; 2008 Aug; 20(2):385-90. PubMed ID: 18636202 [TBL] [Abstract][Full Text] [Related]
8. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Kudo M; Sakaguchi Y; Chung H; Hatanaka K; Hagiwara S; Ishikawa E; Takahashi S; Kitai S; Inoue T; Minami Y; Ueshima K Oncology; 2007; 72 Suppl 1():132-8. PubMed ID: 18087194 [TBL] [Abstract][Full Text] [Related]
9. Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study. Becker G; Allgaier HP; Olschewski M; Zähringer A; Blum HE; Hepatology; 2007 Jan; 45(1):9-15. PubMed ID: 17187405 [TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. Cebon J; Findlay M; Hargreaves C; Stockler M; Thompson P; Boyer M; Roberts S; Poon A; Scott AM; Kalff V; Garas G; Dowling A; Crawford D; Ring J; Basser R; Strickland A; Macdonald G; Green M; Nowak A; Dickman B; Dhillon H; Gebski V; Br J Cancer; 2006 Oct; 95(7):853-61. PubMed ID: 16953241 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study. Alacacioglu A; Somali I; Simsek I; Astarcioglu I; Ozkan M; Camci C; Alkis N; Karaoglu A; Tarhan O; Unek T; Yilmaz U Jpn J Clin Oncol; 2008 Oct; 38(10):683-8. PubMed ID: 18753360 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma. Gallo C; De Maio E; Di Maio M; Signoriello G; Daniele B; Pignata S; Annunziata A; Perrone F; BMC Cancer; 2006 Jul; 6():196. PubMed ID: 16863588 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248 [TBL] [Abstract][Full Text] [Related]
14. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189 [TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study. Verset G; Verslype C; Reynaert H; Borbath I; Langlet P; Vandebroek A; Peeters M; Houbiers G; Francque S; Arvanitakis M; Van Laethem JL Br J Cancer; 2007 Sep; 97(5):582-8. PubMed ID: 17687341 [TBL] [Abstract][Full Text] [Related]
17. [Liver transplantation for hepatocellular carcinoma: a report of 60 cases]. Chen GH; Yang Y; Lu MQ; Cai CJ; He XS; Zhu XF; Xu C; Li H; Huang JF Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):413-6. PubMed ID: 15144669 [TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846 [TBL] [Abstract][Full Text] [Related]
20. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems. Cammà C; Di Marco V; Cabibbo G; Latteri F; Sandonato L; Parisi P; Enea M; Attanasio M; Galia M; Alessi N; Licata A; Latteri MA; Craxì A Aliment Pharmacol Ther; 2008 Jul; 28(1):62-75. PubMed ID: 18373636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]